$SUND
Sundance Strategies, Inc. Stock $sund

$sund Overview Financials Valuation SEC Filings Company Website

2014 Q4 Form 10-Q Financial Statement

#000101041214000185 Filed on November 14, 2014

Income Statement

Concept	2014 Q4	2014 Q3	2013 Q3
Revenue	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$530.0K	$580.0K	$310.0K
YoY Change	51.43%	87.1%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	-$90.00K	-$10.00K	$310.8K
YoY Change	-125.39%	-103.22%
Operating Profit	$89.75K	$9.647K	-$310.8K
YoY Change	-125.32%	-103.1%
Interest Expense	$200.3K	$17.03K	$30.71K
YoY Change	545.62%	-44.54%
% of Operating Profit	223.14%	176.54%
Other Income/Expense, Net	-$195.7K	-$12.55K	-$30.71K
YoY Change	-111.89%	-59.12%
Pretax Income	-$106.0K	-$2.906K	-$341.5K
YoY Change	-108.2%	-99.15%
Income Tax
% Of Pretax Income
Net Earnings	-$106.0K	-$2.906K	-$341.5K
YoY Change	-108.2%	-99.15%
Net Earnings / Revenue
Basic Earnings Per Share		-$0.01
Diluted Earnings Per Share	-$2.547K	-$0.01	-$8.045K
COMMON SHARES
Basic Shares Outstanding	43.19M shares	43.16M shares	42.26M shares
Diluted Shares Outstanding		43.16M shares

Balance Sheet

Concept	2014 Q4	2014 Q3	2013 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$790.0K	$120.0K	$980.0K
YoY Change	558.33%	-87.76%
Cash & Equivalents	$790.5K	$119.7K	$979.6K
Short-Term Investments
Other Short-Term Assets	$0.00	$28.60K
YoY Change
Inventory
Prepaid Expenses	$3.750K	$7.625K
Receivables
Other Receivables
Total Short-Term Assets	$794.2K	$155.9K	$979.6K
YoY Change	536.14%	-84.09%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$17.59M	$17.78M	$12.71M
YoY Change	18.29%	39.89%
Other Assets	$3.575M	$4.376M	$6.414M
YoY Change	-58.3%	-31.77%
Total Long-Term Assets	$17.97M	$18.00M	$12.71M
YoY Change	14.19%	41.59%
TOTAL ASSETS
Total Short-Term Assets	$794.2K	$155.9K	$979.6K
Total Long-Term Assets	$17.97M	$18.00M	$12.71M
Total Assets	$18.77M	$18.16M	$13.69M
YoY Change	18.3%	32.6%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$128.3K	$170.8K	$140.0K
YoY Change	507.15%	22.02%
Accrued Expenses	$163.5K	$146.8K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$1.330M	$1.330M	$3.000M
YoY Change		-55.67%
Long-Term Debt Due	$1.360M	$730.0K	$0.00
YoY Change
Total Short-Term Liabilities	$2.981M	$2.375M	$3.150M
YoY Change	10334.41%	-24.62%	15650.1%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change	-100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change	-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.981M	$2.375M	$3.150M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$2.981M	$2.375M	$3.150M
YoY Change	105.02%	-24.62%	15650.1%
SHAREHOLDERS EQUITY
Retained Earnings	-$478.0K	-$372.1K	-$1.510M
YoY Change	118.56%	-75.36%
Common Stock	$43.19K	$43.19K	$794.8K
YoY Change	-98.7%	-94.57%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$15.78M	$15.78M	$10.54M
YoY Change
Total Liabilities & Shareholders Equity	$18.77M	$18.16M	$13.69M
YoY Change	18.3%	32.6%

Cashflow Statement

Concept	2014 Q4	2014 Q3	2013 Q3
OPERATING ACTIVITIES
Net Income	-$106.0K	-$2.906K	-$341.5K
YoY Change	-108.2%	-99.15%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	$190.0K	-$580.0K	-$910.0K
YoY Change	-107.76%	-36.26%	9000.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$150.0K	$0.00
YoY Change	-82.56%
Cash From Investing Activities	-$150.0K	$0.00
YoY Change	-82.56%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	630.0K	690.0K	630.0K
YoY Change	-74.39%	9.52%	6200.0%
NET CHANGE
Cash From Operating Activities	190.0K	-580.0K	-910.0K
Cash From Investing Activities	-150.0K	0.000
Cash From Financing Activities	630.0K	690.0K	630.0K
Net Change In Cash	670.0K	110.0K	-280.0K
YoY Change	-178.82%	-139.29%
FREE CASH FLOW
Cash From Operating Activities	$190.0K	-$580.0K	-$910.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	640000	USD
	sund	Proceeds From Issuance Of Common Stock Net Of Issuance Costs ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts	6826775	USD
	sund	Proceeds From Issuance Of Common Stock Net Of Issuance Costs ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts		USD
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt		USD
CY2014Q2	us-gaap	Share Price SharePrice	5
CY2014Q3	sund	Working Capital WorkingCapital	-2218624	USD
CY2014Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	660000	shares
CY2014Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3300000	USD
CY2013Q2	sund	Face Value Of Net Insurance Benefits Purchased Under Asset Transfer Agreement FaceValueOfNetInsuranceBenefitsPurchasedUnderAssetTransferAgreement	400000000	USD
CY2013Q4	sund	Face Value Of Net Insurance Benefits Purchased Under Asset Transfer Agreement FaceValueOfNetInsuranceBenefitsPurchasedUnderAssetTransferAgreement	400000000	USD
CY2013Q2	sund	Total Consideration That Would Be Paid By Company If All Net Insurance Benefits Are Provided Under Asset Transfer Agreement TotalConsiderationThatWouldBePaidByCompanyIfAllNetInsuranceBenefitsAreProvidedUnderAssetTransferAgreement	20000000	USD
CY2013Q2	sund	Total Cash Consideration That Would Be Paid By Company If All Net Insurance Benefits Are Provided Under Asset Transfer Agreement TotalCashConsiderationThatWouldBePaidByCompanyIfAllNetInsuranceBenefitsAreProvidedUnderAssetTransferAgreement	8000000	USD
CY2013Q4	sund	Total Cash Consideration That Would Be Paid By Company If All Net Insurance Benefits Are Provided Under Asset Transfer Agreement TotalCashConsiderationThatWouldBePaidByCompanyIfAllNetInsuranceBenefitsAreProvidedUnderAssetTransferAgreement	12000000	USD
CY2013Q2	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.040	pure
CY2013Q2	us-gaap	Restructuring And Related Cost Incurred Cost RestructuringAndRelatedCostIncurredCost	4000000	USD
CY2013Q2	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	24000000	USD
CY2013Q2	sund	Total Notes Payable That Would Be Issued By Company If All Net Insurance Benefits Are Provided Under Asset Transfer Agreement TotalNotesPayableThatWouldBeIssuedByCompanyIfAllNetInsuranceBenefitsAreProvidedUnderAssetTransferAgreement	12000000	USD
CY2013Q2	us-gaap	Other Notes Payable OtherNotesPayable	12000000	USD
CY2013Q4	sund	Advance To Consultant For Services AdvanceToConsultantForServices	25000	USD
CY2014Q1	sund	Valueof Qualified Net Insurance Benefits ValueofQualifiedNetInsuranceBenefits	90600000	USD
CY2014Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	170826	USD
CY2014Q3	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	730000	USD
CY2014Q1	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	90000	USD
CY2014Q3	us-gaap	Liabilities Current LiabilitiesCurrent	2374511	USD
CY2014Q1	us-gaap	Liabilities Current LiabilitiesCurrent	142915	USD
CY2013Q4	sund	Structuring And Consulting Agreement Terms StructuringAndConsultingAgreementTerms	In the event the Qualified NIBs delivered are less than $300,000,000 in face value under the DMF Agreement, Del Mar and Europa shall be jointly and severally liable for liquidated damages equal to the aggregate of the cash payment under the Del Mar ATA and all of the costs advanced, reduced by the pro rata percentage of the Qualified NIBs delivered and accepted by the Company, multiplied by two; and if at least $300,000,000 in Qualified NIBs are delivered and accepted, then the cash payment and all costs will not be doubled if they are paid within 90 days.
CY2013Q2	sund	Structuring And Consulting Agreement Terms StructuringAndConsultingAgreementTerms	The Company is required to pay a structuring fee of 1% of the face amount of the life insurance policies underlying all NIBs introduced and acquired, payable as follows: 50% of the fee on the delivery of the NIBs; and the remaining 50% being payable on the conversion of the NIBs to Qualified NIBs as defined in the Del Mar ATA.
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	740000	USD
CY2014Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	1455904	USD
CY2014Q3	us-gaap	Liabilities Liabilities	2374511	USD
	us-gaap	Description Of New Accounting Pronouncements Not Yet Adopted DescriptionOfNewAccountingPronouncementsNotYetAdopted	<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <div> <p style=" margin: 0pt; text-align: justify; font-family : Times New Roman;"><strong><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">(2) NEW ACCOUNTING PRONOUNCEMENTS</font></font></strong></p> <p style=" margin: 0pt; text-align: justify; font-family : Times New Roman;"> </p> <p style=" margin: 0pt; text-align: justify; text-indent: 36pt; font-family : Times New Roman;"><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">In </font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">May 2014</font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">, the Financial Accounting Standards Board (FASB) issued Accounting Standard Update (ASU) 2014-09 Revenue from Contracts with Customers, which provides a single, comprehensive revenue recognition model for all contracts with customers. The core principal of this ASU is that an entity should recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This ASU also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. This ASU is effective for annual periods, and interim periods within those annual periods, beginning after </font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">December 15, 2016</font></font><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">. Early adoption is not permitted and companies can transition to the new standard under the full retrospective method or the modified retrospective method. The Company does not believe adoption of this ASU will have a material impact on its financial statements.</font></font></p> <p style=" margin: 0pt; text-align: justify; text-indent: 36pt; font-family : Times New Roman;"> </p> <p style=" margin: 0pt; text-align: justify; text-indent: 36pt; font-family : Times New Roman;"><font style=" font-size: 10pt;"><font style=" font-family : Times New Roman;">In August 2014, the FASB issued ASU 2014-15 Presentation of Financial StatementsGoing Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern. The new standard provides guidance around management's responsibility to evaluate whether there is substantial doubt about an entity's ability to continue as a going concern and to provide related footnote disclosures. The new standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2016. Early adoption is permitted. The adoption of this standard is not expected to have a material impact on the Company's financial statements.</font></font></p> <p style=" margin: 0pt; text-align: justify; text-indent: 36pt; font-family : Times New Roman;"> </p> <div> <div style=" display: inline; font-size: 13.333333015441895px; font-family : Times New Roman; font-variant: normal; font-weight: normal; font-style: normal; text-decoration: none solid rgb(0, 0, 0); color: rgb(0, 0, 0);">              <font style=" font-size: 10pt;">The Company has reviewed all other recently issued, but not yet adopted, accounting standards in order to determine their effects, if any, on its results of operations, financial position or cash flows. Based on that review, the Company believes that none of these pronouncements will have a significant effect on its financial statements.</font></div> </div> </div> </div>
CY2014Q1	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	13767	USD
CY2014Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	18001028	USD
CY2014Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	16703040	USD
CY2014Q3	us-gaap	Assets Assets	18156915	USD
CY2014Q1	us-gaap	Assets Assets	17080252	USD
CY2014Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	52915	USD
CY2014Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	146809	USD
CY2014Q3	us-gaap	Notes Payable Current NotesPayableCurrent	1326876	USD
CY2014Q1	us-gaap	Liabilities Liabilities	1598819	USD
CY2014Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2014Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2014Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2014Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2014Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2014Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43015941	shares
CY2014Q3	us-gaap	Common Stock Value CommonStockValue	43186	USD
CY2014Q1	us-gaap	Common Stock Value CommonStockValue	43017	USD
CY2014Q1	us-gaap	Receivable From Shareholders Or Affiliates For Issuance Of Capital Stock ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock	1500	USD
CY2014Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	16111277	USD
CY2014Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	15050705	USD
CY2014Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock		USD
CY2014Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	700000	USD
CY2014Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-372059	USD
CY2014Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-310789	USD
CY2014Q3	us-gaap	Stockholders Equity StockholdersEquity	15782404	USD
CY2014Q1	us-gaap	Stockholders Equity StockholdersEquity	15481433	USD
CY2014Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	18156915	USD
CY2014Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	17080252	USD
CY2014Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent		USD
CY2014Q1	us-gaap	Notes Payable Current NotesPayableCurrent		USD
CY2014Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable		USD
CY2014Q3	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2014Q1	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2014Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2014Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2014Q3	us-gaap	Receivable From Shareholders Or Affiliates For Issuance Of Capital Stock ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock		USD
CY2014Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	7625	USD
CY2014Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2000	USD
CY2014Q3	us-gaap	Assets Current AssetsCurrent	155887	USD
CY2014Q1	us-gaap	Assets Current AssetsCurrent	377212	USD
CY2014Q3	us-gaap	Life Settlement Contracts Investment Method Carrying Amount LifeSettlementContractsInvestmentMethodCarryingAmount	13399562	USD
CY2014Q1	us-gaap	Life Settlement Contracts Investment Method Carrying Amount LifeSettlementContractsInvestmentMethodCarryingAmount	12243411	USD
CY2014Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4376419	USD
CY2014Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3584862	USD
CY2014Q3	us-gaap	Notes Receivable Net NotesReceivableNet	211000	USD
CY2014Q1	us-gaap	Notes Receivable Net NotesReceivableNet	861000	USD
CY2014Q3	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	14047	USD
CY2014Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	43015941	shares
CY2014Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2014Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43185941	shares
CY2014Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2014Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2014Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	43185941	shares
CY2014Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2014Q3	us-gaap	Interest Income Operating InterestIncomeOperating	592653	USD
CY2013Q3	us-gaap	Interest Income Operating InterestIncomeOperating		USD
	us-gaap	Interest Income Operating InterestIncomeOperating	1156151	USD
	us-gaap	Interest Income Operating InterestIncomeOperating		USD
CY2014Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	583006	USD
CY2013Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	310809	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1199372	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1344674	USD
CY2014Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	9647	USD
CY2013Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-310809	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-43221	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1344674	USD
CY2014Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		USD
CY2013Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	6303	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		USD
CY2014Q3	us-gaap	Interest Income Other InterestIncomeOther	4478	USD
CY2013Q3	us-gaap	Interest Income Other InterestIncomeOther		USD
	us-gaap	Interest Income Other InterestIncomeOther	8820	USD
	us-gaap	Interest Income Other InterestIncomeOther	21	USD
CY2014Q3	us-gaap	Interest Expense InterestExpense	17031	USD
CY2013Q3	us-gaap	Interest Expense InterestExpense	30709	USD
	us-gaap	Interest Expense InterestExpense	33172	USD
	us-gaap	Interest Expense InterestExpense	60782	USD
CY2014Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-12553	USD
CY2013Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-30709	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-18049	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-60761	USD
CY2014Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-2906	USD
CY2013Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-341518	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-61270	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1405435	USD
CY2014Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		USD
CY2013Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		USD
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	-2906	USD
CY2013Q3	us-gaap	Net Income Loss NetIncomeLoss	-341518	USD
CY2014Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.01
CY2013Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.01
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.01
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.03
CY2014Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	43163575	shares
CY2013Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	42261441	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	43090561	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	41781441	shares
CY2014Q3	us-gaap	Other Assets Current OtherAssetsCurrent	28600	USD
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	28600	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	5625	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense		USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	150000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		USD
	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity		USD
	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity	752500	USD
CY2014Q3	us-gaap	Life Settlement Contracts Investment Method Face Value LifeSettlementContractsInvestmentMethodFaceValue	217000000	USD
CY2014Q3	sund	Life Settlement Contracts Investment Ownership Percentage LifeSettlementContractsInvestmentOwnershipPercentage	1	pure
CY2013Q1	us-gaap	Life Settlement Contracts Investment Method Carrying Amount LifeSettlementContractsInvestmentMethodCarryingAmount	12243411	USD
CY2014	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments		USD
CY2014	us-gaap	Interest Income Operating InterestIncomeOperating		USD
	sund	Distribution Of Life Settlement Contract Investments DistributionOfLifeSettlementContractInvestments		USD
CY2014	sund	Distribution Of Life Settlement Contract Investments DistributionOfLifeSettlementContractInvestments		USD
	us-gaap	Impairment Of Investments ImpairmentOfInvestments		USD
CY2014	us-gaap	Impairment Of Investments ImpairmentOfInvestments		USD
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	100000	USD
CY2014Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
	dei	Entity Registrant Name EntityRegistrantName	Sundance Strategies, Inc.
	dei	Entity Central Index Key EntityCentralIndexKey	0001171838
	dei	Document Type DocumentType	10-Q
	dei	Document Period End Date DocumentPeriodEndDate	2014-09-30
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2014Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	43185941	shares
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2

Files In Submission

Name	View Source	Status
0001010412-14-000185-index-headers.html	Edgar Link	pending
0001010412-14-000185-index.html	Edgar Link	pending
0001010412-14-000185.txt	Edgar Link	pending
0001010412-14-000185-xbrl.zip	Edgar Link	pending
ex311.htm	Edgar Link	pending
ex312.htm	Edgar Link	pending
ex32.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
formofextensionofluloagreeme.htm	Edgar Link	pending
qtr2093014lwbclean6withallco.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
sund-20140930.xml	Edgar Link	completed
sund-20140930.xsd	Edgar Link	pending
sund-20140930_cal.xml	Edgar Link	unprocessable
sund-20140930_def.xml	Edgar Link	unprocessable
sund-20140930_lab.xml	Edgar Link	unprocessable
sund-20140930_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SUND
Sundance Strategies, Inc. Stock $sund

2014 Q4 Form 10-Q Financial Statement

#000101041214000185 Filed on November 14, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SUND Sundance Strategies, Inc. Stock $sund

2014 Q4 Form 10-Q Financial Statement

#000101041214000185 Filed on November 14, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SUND
Sundance Strategies, Inc. Stock $sund